125 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
to time, we may seek additional financing to provide the capital required to expand research and development (“R&D”) initiatives and/or working capital … that it will be unable to carry out its business plans, including R&D development and expansion of production facilities. Currently, the Company has had to put
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
seek additional financing to provide the capital required to expand research and development (“R&D”) initiatives and/or working capital, as well … to carry out its business plans, including R&D development and expansion of production facilities. Currently, the Company has had to put several projects
8-K
EX-99.1
ABVC
ABVC BioPharma Inc
26 Mar 24
Entry into a Material Definitive Agreement
8:35am
generation with access to an even broader audience. With this new licensing agreement in place, ABVC will continue to serve as the R&D partner
DEFA14A
fo3nxo
25 Mar 24
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
xbg7a ukozt2ts8ogc1
14 Mar 24
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
9:04am
8-K
EX-99.1
i2mil4swx wx75og
8 Feb 24
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
9:30am
424B4
wi28k j8jpbuog4
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
jxmk79h
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
pwq4p 41278hpcw6vj
17 Nov 23
Prospectus supplement
5:00pm
8-K
EX-99.1
qgv5 qhspfck4xtg
15 Nov 23
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
8:41am